✦ LIBER ✦

Menstrual History and Quality-of-Life Outcomes in Women With Node-Positive Breast Cancer Treated With Adjuvant Therapy on the NSABP B-30 Trial

✍ Scribed by Vassilopoulou-Sellin, R.

Book ID: 121984067
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 227 KB
Volume: 22
Category: Article
ISSN: 1043-321X
DOI: 10.1016/j.breastdis.2011.10.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of adjuvant therapy on quality of

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer

✍ International Breast Cancer Study Group; C. Hürny; J. Bernhard; M. Castiglione-G 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 855 KB

Definitive Results of a Phase III Adjuva

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

✍ Swain, S. M.; Tang, G.; Geyer, C. E.; Rastogi, P.; Atkins, J. N.; Donnellan, P. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 777 KB

Randomized trial to evaluate the additio

Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer

✍ James N. Ingle; Lloyd K. Everson; H. Sam Wieand; Stephen A. Cullinan; Lester E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Seven-Year Follow-Up Assessment of Cardi

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

✍ Zibelman, M.; Goldstein, L.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

The influence of classical prognostic fa

The influence of classical prognostic factors and adjuvant chemotherapy on disease outcome in early grade 3 node-negative, and 1–3 node-positive breast cancer patients treated with adjuvant cyclophosphamide, methotrexate and fluorouracil (CMF), or untreated patients

✍ S Susnjar; I Kezic; Z Neskovic-Konstantinovic; D Gavrilovic; D Nikolic-Vukosavlj 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB

762 Prognostic and Predictive Value of T

762 Prognostic and Predictive Value of TP53 Mutations in Node-positive Breast Cancer Patients Treated with Anthracycline-or Anthracycline/taxane Based Adjuvant Therapy – Results From the BIG 02-98 Phase III Trial

✍ M. Olivier; L. Fernández-Cuesta; C. Oakman; E. Quinaux; M.S. Dolci; P.A. Francis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB